A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2011
11/02/2011	CN102229924A Polyethylene glycol-modified Serratia protein-digesting enzyme as well as preparation method and application thereof
11/02/2011	CN102229921A Preparation method of trichoderma longibrachiatum lyase for treating fungal diseases
11/02/2011	CN102229668A GLP-1 (glucagon-like peptide-1) derivative and application thereof
11/02/2011	CN102229667A Polyethylene glycol modified porcine alpha-interferon, preparation method and application thereof
11/02/2011	CN102229666A Preparation method and application of animal-derived cationic antimicrobial peptides
11/02/2011	CN102229664A Recombinant melittin and application thereof
11/02/2011	CN102229660A Truncated human papillomavirus 33 type L1 protein
11/02/2011	CN102229659A Rana nigromaculata antibacterial peptide and gene and application thereof
11/02/2011	CN102229658A Anti-rheumatoid arthritis polypeptide and its application in pharmacy
11/02/2011	CN102229657A Polypeptide against rheumatoid arthritis and application thereof in pharmacy
11/02/2011	CN102229656A Polypeptide against rheumatoid arthritis and application thereof in pharmacy
11/02/2011	CN102229655A Polypeptide resistant to rheumatoid arthritis and application of polypeptide in pharmacy
11/02/2011	CN102229654A Polypeptide resistant to rheumatoid arthritis and application of polypeptide in pharmacy
11/02/2011	CN102229653A Polypeptide resistant to rheumatoid arthritis and application of polypeptide in pharmacy
11/02/2011	CN102229652A Polypeptide against rheumatoid arthritis and application thereof in pharmacy
11/02/2011	CN102229651A Amyloid protein intra-membrane segment for treating Alzheimer disease and application thereof
11/02/2011	CN102229650A High purity lipopeptides, lipopeptide micelles and processes for preparing same
11/02/2011	CN102228700A Method for constructing insulin resistance animal model
11/02/2011	CN102228695A Method for preparing basic fibroblast growth factor sustained-release carrier
11/02/2011	CN102228694A Active PDGFR (Platelet-derived Growth Factor Receptor)-beta targeting drug delivery system and preparation method thereof
11/02/2011	CN102228684A Chinese medicinal composition for enhancing immunity of children and application thereof
11/02/2011	CN102228683A Method for preparing freeze-dried human blood coagulation factor VIII
11/02/2011	CN102228682A Medicinal composition for treating increased blood viscosity and blood supply insufficiency of brain tissues
11/02/2011	CN102228681A Fish spawning inducer and spawning induction method
11/02/2011	CN102228680A Thymosin phospholipids/bile salt compound micelle and preparation method and preparation thereof
11/02/2011	CN102228679A Chicken interferon gamma combined medicament and application
11/02/2011	CN102228678A Carbetocin pharmaceutical composition and preparation method thereof
11/02/2011	CN102228677A 21 (R) argatroban intravenous injection containing acid as solubiliser
11/02/2011	CN102228676A Heparolysate injection pharmaceutical composition
11/02/2011	CN102228469A Nano-selenium particles and preparation method thereof
11/02/2011	CN102228444A N(2)-L-alanyl-L-glutamine preparation for injection and preparation method thereof
11/02/2011	CN102228437A Co-immobilized TNF-a/IFN-g/DOX/FA/Fe3O4-OA magnetic targeted nanoparticle as well as preparation method and application thereof
11/02/2011	CN102228426A 21(R) argatroban intravenous injection with alcohol as solubilizer
11/02/2011	CN102228425A Tumor-targeted magnetic hydrogel nanoscale medicine delivery system and construction method and application thereof
11/02/2011	CN101565462B Large yellow croaker BPI-BN protein, primer and applications thereof in preparing antibiotic drugs
11/02/2011	CN101230090B Blood peptide X and derivative thereof as well as preparation method and use thereof
11/02/2011	CN101193652B Pharmaceutical formulations comprising incretin peptide and aprotic polar solvent
11/02/2011	CN101168044B Product formula for lady daily nursing gel
11/02/2011	CN101104078B Polypeptide and protein medicine polyethylene coupling compound
11/01/2011	USRE42889 α- and β- amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/01/2011	US8048995 Human skeletal muscle-specific ubiquitin-conjugating enzyme
11/01/2011	US8048993 Heparanase specific molecular probes and their use in research and medical applications
11/01/2011	US8048991 Antibody to an integrin heterodimer and/or a subunit thereof
11/01/2011	US8048990 Modified vitamin K-dependent polypeptides
11/01/2011	US8048985 Vascular Leak Syndrome; polypeptide toxophore from a DT; has cytotoxicity comparable to that of a DT molecule
11/01/2011	US8048984 Human GIL-19/AE289 proteins
11/01/2011	US8048918 Treatment of hyperproliferative diseases
11/01/2011	US8048862 Macrocyclic inhibitors of hepatitis C virus replication
11/01/2011	US8048859 Use of repeat sequence protein polymers in personal care compositions
11/01/2011	US8048858 Use of poly-α2,8-sialic acid mimetic peptides to modulate NCAM functions
11/01/2011	US8048857 Flowable carrier compositions and methods of use
11/01/2011	US8048856 Treatment methods using a heat stable oxygen carrier-containing pharmaceutical composition
11/01/2011	US8048855 Method for suppressing graft-versus-host-disease
11/01/2011	US8048854 Amidated insulin glargine
11/01/2011	US8048853 Process for preparing pharmaceutical compound and intermediates thereof
11/01/2011	US8048852 Antimicrobial compounds and formulations
11/01/2011	US8048851 Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
11/01/2011	US8048850 Anticancer agents
11/01/2011	US8048849 Long-acting polypeptides and methods of producing same
11/01/2011	US8048848 Long-acting interferons and derivatives thereof and methods thereof
11/01/2011	US8048847 Derivatives of the IL-2 receptor gamma chain, their production and use
11/01/2011	US8048846 Topical hair treatment to reduce damage caused by flexure and/or abrasion
11/01/2011	US8048676 Systems of diagnosing cervical cancer
11/01/2011	US8048672 Comprises nucleotide sequences coding transcription factor for treating infections, multiple sclerosis, arthritis and autoimmune disease
11/01/2011	US8048646 NELL peptide expression systems and bone formation activity of NELL peptide
11/01/2011	US8048643 FRET protease assays for clostridial toxins
11/01/2011	US8048637 Diagnostic composition and method for the detection of a Trichinella infection
11/01/2011	US8048446 Electrospun blends of natural and synthetic polymer fibers as tissue engineering scaffolds
11/01/2011	US8048443 Pliable medical device and method of use
11/01/2011	US8048437 Medical device with surface coating comprising bioactive compound
11/01/2011	US8048424 Insect poison allergens with reduced IgE reactivity and method for producing the same
11/01/2011	US8048423 Treating warts, corns, bunions, ulcers, calluses, neuromas, ulcers, and hammertoes; reducing pain, size of the skin disorder, or inflammation
11/01/2011	US8048418 Therapeutic methods for inhibiting tumor growth with combination of Dll4 antagonists and VEGF antagonists
11/01/2011	US8048417 Anti-human tenascin monoclonal antibody
11/01/2011	US8048415 Compositions and methods for promoting or inhibiting angiogenesis
11/01/2011	US8048414 Antivenom composition containing Fab fragments
11/01/2011	US8048412 Enzyme with microbial lysis activity from Trichoderma reesei
11/01/2011	US8048015 Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
11/01/2011	CA2697570C Reduced volume formulation of glatiramer acetate and methods of administration
11/01/2011	CA2507766C Novel dry powder inhalation system for transpulmonary administration
11/01/2011	CA2490351C Process for producing sustained-release composition
11/01/2011	CA2490277C Use of vasopeptidase inhibitors in the treatment of nephropathy
11/01/2011	CA2483750C Biologically active compounds for the modification of bodily odours
11/01/2011	CA2483329C Apparatus and methods for enzymatic escharotomy in burn induced compartment syndrome
11/01/2011	CA2473461C Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
11/01/2011	CA2468254C Therapeutic coating for an intravascular implant
11/01/2011	CA2458813C Anti-cancer cyclopenta[g]quinazoline compounds
11/01/2011	CA2431241C Amphiphilic polymers for medical applications
11/01/2011	CA2402489C Oral tolerance induction by collagen to prevent allograft rejection
11/01/2011	CA2402247C Biodegradable immunomodulatory formulations and methods for use thereof
11/01/2011	CA2396718C Pre-transplant accomodated organs resistant to anti-donor immunity
11/01/2011	CA2337967C Recombinant uricase protein
11/01/2011	CA2295986C Novel antimicrobial polypeptide and methods of use
11/01/2011	CA2275890C Stable liquid interferon formulations
11/01/2011	CA2235443C Novel insulin derivatives having a rapid onset of action
11/01/2011	CA2203622C Compounds, pharmaceutical composition and diagnostic device comprising them and their use
11/01/2011	CA2176942C Bmp-12, bmp-13 and tendon-inducing compositions thereof
11/01/2011	CA2105903C Methods and compositions for the detection of soluble .beta.-amyloid peptide
10/2011
10/27/2011	WO2011133964A2 Methods and compositions for preserving photoreceptor and retinal pigment epithelial cells
10/27/2011	WO2011133960A2 Lysosomal storage disease enzyme

1 ... 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 ... 3163